448 related articles for article (PubMed ID: 36875093)
1. The role of AMPK in cancer metabolism and its impact on the immunomodulation of the tumor microenvironment.
Keerthana CK; Rayginia TP; Shifana SC; Anto NP; Kalimuthu K; Isakov N; Anto RJ
Front Immunol; 2023; 14():1114582. PubMed ID: 36875093
[TBL] [Abstract][Full Text] [Related]
2. Immune-mediated anti-tumor effects of metformin; targeting metabolic reprogramming of T cells as a new possible mechanism for anti-cancer effects of metformin.
Bahrambeigi S; Shafiei-Irannejad V
Biochem Pharmacol; 2020 Apr; 174():113787. PubMed ID: 31884044
[TBL] [Abstract][Full Text] [Related]
3. mTOR-Mediated Regulation of Immune Responses in Cancer and Tumor Microenvironment.
Mafi S; Mansoori B; Taeb S; Sadeghi H; Abbasi R; Cho WC; Rostamzadeh D
Front Immunol; 2021; 12():774103. PubMed ID: 35250965
[TBL] [Abstract][Full Text] [Related]
4. Natural activators of adenosine 5'-monophosphate (AMP)-activated protein kinase (AMPK) and their pharmacological activities.
Vazirian M; Nabavi SM; Jafari S; Manayi A
Food Chem Toxicol; 2018 Dec; 122():69-79. PubMed ID: 30290216
[TBL] [Abstract][Full Text] [Related]
5. AMPK activation inhibits the functions of myeloid-derived suppressor cells (MDSC): impact on cancer and aging.
Salminen A; Kauppinen A; Kaarniranta K
J Mol Med (Berl); 2019 Aug; 97(8):1049-1064. PubMed ID: 31129755
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in the role of AMP-activated protein kinase in metabolic reprogramming of metastatic cancer cells: targeting cellular bioenergetics and biosynthetic pathways for anti-tumor treatment.
Tyszka-Czochara M; Konieczny P; Majka M
J Physiol Pharmacol; 2018 Jun; 69(3):. PubMed ID: 30279304
[TBL] [Abstract][Full Text] [Related]
7. AMPK as a potential anticancer target - friend or foe?
Chuang HC; Chou CC; Kulp SK; Chen CS
Curr Pharm Des; 2014; 20(15):2607-18. PubMed ID: 23859619
[TBL] [Abstract][Full Text] [Related]
8. Indoleamine 2,3-dioxygenase regulates anti-tumor immunity in lung cancer by metabolic reprogramming of immune cells in the tumor microenvironment.
Schafer CC; Wang Y; Hough KP; Sawant A; Grant SC; Thannickal VJ; Zmijewski J; Ponnazhagan S; Deshane JS
Oncotarget; 2016 Nov; 7(46):75407-75424. PubMed ID: 27705910
[TBL] [Abstract][Full Text] [Related]
9. The role of AMPK in macrophage metabolism, function and polarisation.
Cui Y; Chen J; Zhang Z; Shi H; Sun W; Yi Q
J Transl Med; 2023 Dec; 21(1):892. PubMed ID: 38066566
[TBL] [Abstract][Full Text] [Related]
10. Targeting AMPK for cancer prevention and treatment.
Li W; Saud SM; Young MR; Chen G; Hua B
Oncotarget; 2015 Apr; 6(10):7365-78. PubMed ID: 25812084
[TBL] [Abstract][Full Text] [Related]
11. AMPK signaling and its targeting in cancer progression and treatment.
Hsu CC; Peng D; Cai Z; Lin HK
Semin Cancer Biol; 2022 Oct; 85():52-68. PubMed ID: 33862221
[TBL] [Abstract][Full Text] [Related]
12. AMPK promotes antitumor immunity by downregulating PD-1 in regulatory T cells via the HMGCR/p38 signaling pathway.
Pokhrel RH; Acharya S; Ahn JH; Gu Y; Pandit M; Kim JO; Park YY; Kang B; Ko HJ; Chang JH
Mol Cancer; 2021 Oct; 20(1):133. PubMed ID: 34649584
[TBL] [Abstract][Full Text] [Related]
13. An integrative pan-cancer investigation reveals common genetic and transcriptional alterations of AMPK pathway genes as important predictors of clinical outcomes across major cancer types.
Chang WH; Lai AG
BMC Cancer; 2020 Aug; 20(1):773. PubMed ID: 32807122
[TBL] [Abstract][Full Text] [Related]
14. Nutritional Modulation of AMPK-Impact upon Metabolic-Inflammation.
Lyons CL; Roche HM
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30304866
[TBL] [Abstract][Full Text] [Related]
15. Cross-talk between AMPK and mTOR in regulating energy balance.
Xu J; Ji J; Yan XH
Crit Rev Food Sci Nutr; 2012; 52(5):373-81. PubMed ID: 22369257
[TBL] [Abstract][Full Text] [Related]
16. Reprogramming of glutamine metabolism and its impact on immune response in the tumor microenvironment.
Ma G; Zhang Z; Li P; Zhang Z; Zeng M; Liang Z; Li D; Wang L; Chen Y; Liang Y; Niu H
Cell Commun Signal; 2022 Jul; 20(1):114. PubMed ID: 35897036
[TBL] [Abstract][Full Text] [Related]
17. The energy sensor AMPK regulates T cell metabolic adaptation and effector responses in vivo.
Blagih J; Coulombe F; Vincent EE; Dupuy F; Galicia-Vázquez G; Yurchenko E; Raissi TC; van der Windt GJ; Viollet B; Pearce EL; Pelletier J; Piccirillo CA; Krawczyk CM; Divangahi M; Jones RG
Immunity; 2015 Jan; 42(1):41-54. PubMed ID: 25607458
[TBL] [Abstract][Full Text] [Related]
18. The AMP-activated protein kinase (AMPK) and cancer: many faces of a metabolic regulator.
Faubert B; Vincent EE; Poffenberger MC; Jones RG
Cancer Lett; 2015 Jan; 356(2 Pt A):165-70. PubMed ID: 24486219
[TBL] [Abstract][Full Text] [Related]
19. The Anticancer Agent, Di-2-Pyridylketone 4,4-Dimethyl-3-Thiosemicarbazone (Dp44mT), Up-Regulates the AMPK-Dependent Energy Homeostasis Pathway in Cancer Cells.
Krishan S; Richardson DR; Sahni S
Biochim Biophys Acta; 2016 Dec; 1863(12):2916-2933. PubMed ID: 27639899
[TBL] [Abstract][Full Text] [Related]
20. Metabolism and polarization regulation of macrophages in the tumor microenvironment.
Wang J; Mi S; Ding M; Li X; Yuan S
Cancer Lett; 2022 Sep; 543():215766. PubMed ID: 35690285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
